SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-071813
Filing Date
2024-06-14
Accepted
2024-06-14 16:51:28
Documents
19
Period of Report
2024-06-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2416818d3_8k.htm   iXBRL 8-K 36801
2 EXHIBIT 1.1 tm2416818d3_ex1-1.htm EX-1.1 245490
3 EXHIBIT 4.1 tm2416818d3_ex4-1.htm EX-4.1 68866
4 EXHIBIT 5.1 tm2416818d3_ex5-1.htm EX-5.1 15425
5 EXHIBIT 99.1 tm2416818d3_ex99-1.htm EX-99.1 10771
9 GRAPHIC tm2416818d3_ex5-1img001.jpg GRAPHIC 5897
10 GRAPHIC tm2416818d3_ex99-1img001.jpg GRAPHIC 3171
  Complete submission text file 0001104659-24-071813.txt   655507

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA rzlt-20240613.xsd EX-101.SCH 3024
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE rzlt-20240613_lab.xml EX-101.LAB 34240
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rzlt-20240613_pre.xml EX-101.PRE 22365
22 EXTRACTED XBRL INSTANCE DOCUMENT tm2416818d3_8k_htm.xml XML 3679
Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39683 | Film No.: 241045647
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)